Globus Medical (NYSE:GMED) to Repurchase $500.00 million in Outstanding Stock
Globus Medical (NYSE:GMED – Get Free Report) announced that its Board of Directors has approved a stock buyback plan on Thursday, May 15th, RTT News reports. The company plans to buyback $500.00 million in outstanding shares. This buyback authorization permits the medical device company to purchase up to 6.3% of its shares through open market […]
